1. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
    Wen-wei Chang, 0 CrossRef
  2. Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury
    Shixin Gu et al, 2017, IJMS CrossRef
  3. Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC
    Rosalba D’Alessandro et al, 2015, Expert Opinion on Pharmacotherapy CrossRef
  4. Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma
    Mankgopo M. Kgatle et al, 2016, BioMed Research International CrossRef
  5. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
    Xiaoli Pang et al, 2015 CrossRef
  6. Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma
    Yu Gong et al, 2017 CrossRef
  7. MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma
    Jiuhong Ma et al, 2017 CrossRef
  8. Long non-coding RNAs involved in autophagy regulation
    Lixian Yang et al, 2017, Cell Death Dis CrossRef
  9. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Huicong Li et al, 2017, Biomed Pharmacother CrossRef
  10. Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
    Tianhao Sun et al, 2018, Mol Carcinog CrossRef
  11. Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks
    Shruthi Kanthaje et al, 2017, Hepatol Res CrossRef
  12. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma
    Fang-Hui Ren et al, 2018, BMC Cancer CrossRef
  13. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
    Daniela Pollutri et al, 2018, Cell Death Dis CrossRef
  14. microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer
    Aijun Yang et al, 2017 CrossRef
  15. Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer
    Xianhua Meng et al, 2017 CrossRef
  16. Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST
    Juozas Kupcinskas, 2018, IJMS CrossRef
  17. MicroRNA-494 improves functional recovery and inhibits apoptosis by modulating PTEN/AKT/mTOR pathway in rats after spinal cord injury
    Huaguang Zhu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  18. LncRNA ATB promotes proliferation and metastasis in A549 cells by down-regulation of microRNA-494
    Yiwei Cao et al, 2018, J. Cell. Biochem. CrossRef
  19. Roles of microRNA in liver cancer
    Junyan Tao et al, 2018, Liver Research CrossRef
  20. Host MicroRNA hsa-miR-494-3p Promotes EV71 Replication by Directly Targeting PTEN
    Qing Zhao et al, 2018, Front. Cell. Infect. Microbiol. CrossRef
  21. Novel biomarkers in hepatocellular carcinoma.
    Felice De Stefano et al, 2018, Dig Liver Dis CrossRef
  22. Non-coding RNA in drug resistance of hepatocellular carcinoma
    Bisha Ding et al, 2018, Biosci. Rep. CrossRef
  23. Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies
    Mengyan Xie et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
  24. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells
    Chen Tian et al, 2017, J. Cell. Physiol. CrossRef
  25. MiR-876-5p regulates proliferation, migration and apoptosis of cervical cancer cells through targeting KPNA4
    Hongwei Lei et al, 2018, Pathology - Research and Practice CrossRef
  26. Resveratrol Inhibits the TGF-β1-Induced Proliferation of Cardiac Fibroblasts and Collagen Secretion by Downregulating miR-17 in Rat
    Yao Zhang et al, 2018, BioMed Research International CrossRef
  27. MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer
    Qiao Zhang et al, 2019, Sci Rep CrossRef
  28. ncRNAs associated with drug resistance and the therapy of digestive system neoplasms
    Wei Feng et al, 2019, J Cell Physiol CrossRef
  29. Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion
    Zhongxian Tian et al, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  30. MEG3 interacted with miR‐494 to repress bladder cancer progression through targeting PTEN
    Guang Shan et al, 2019, J Cell Physiol CrossRef
  31. MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma
    Deshun Huang et al, 2019, CBM CrossRef
  32. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R
    Na Li et al, 2016, Tumor Biol. CrossRef
  33. MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
    Punashi Dutta et al, 2016, BMC Cancer CrossRef
  34. Therapeutic Potential of miR-494 in Thrombosis and Other Diseases: A Review
    Jasmine Tay et al, 2016, Aust. J. Chem. CrossRef
  35. MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development
    Liangcai Wu et al, 2017, Hepatol Res CrossRef
  36. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494
    Xiaoni Han et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  37. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway
    Mingyue Zhu et al, 2017, Int. J. Cancer CrossRef
  38. MicroRNA-494 Inhibits the LRG1 Expression to Induce Proliferation and Migration of VECs in Rats following Myocardial Infarction
    Qiang Su et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
  39. Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression
    Laura Patras et al, 2019, CPD CrossRef
  40. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma
    Jian Li et al, 2019, CBM CrossRef
  41. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
    Farzad Rahmani et al, 2019, J Cell Physiol CrossRef
  42. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Ling Wei et al, 2019, Mol Cancer CrossRef
  43. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
    Yongting Lai et al, 2019, Front. Oncol. CrossRef
  44. Transcriptome sequencing of circular RNA reveals a novel circular RNA-has_circ_0114427 in the regulation of inflammation in acute kidney injury
    Yiling Cao et al, 2020 CrossRef
  45. MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells
    Pei-Ling Hsieh et al, 2020, Cancers CrossRef
  46. Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study
    Ami R Zota et al, 2020, Genet Epigenet CrossRef
  47. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma
    Ioannis A. Ziogas et al, 2019, MIRNA CrossRef
  48. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy
    Yu-Chieh Lee et al, 2017, Oncotarget CrossRef
  49. miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6
    Sebastiano Rontauroli et al, 2017, Oncotarget CrossRef
  50. miR-494-3p is a novel tumor driver of lung carcinogenesis
    Alice Faversani et al, 2017, Oncotarget CrossRef
  51. Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin
    Sergio Rizzo et al, 2017, Oncotarget CrossRef
  52. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method
    Cheng-Wei Li et al, 2016, Oncotarget CrossRef
  53. Downregulation of MicroRNA-494 inhibits the TGF-β1/Smads signaling pathway and prevents the development of hypospadias through upregulating Nedd4L
    Run-Hui Tian et al, 2020, Experimental and Molecular Pathology CrossRef
  54. An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
    Shuyao Tang et al, 2016, Oncotarget CrossRef
  55. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
    Debashri Manna et al, 2020, Cancers CrossRef
  56. Overexpression of microRNA-21-5p prevents the oxidative stress-induced apoptosis of RSC96 cells by suppressing autophagy
    Meng Yuan et al, 2020, Life Sciences CrossRef
  57. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1
    Ying Yang et al, 2018, Int J Oncol CrossRef
  58. Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma
    Yu‑Yuan Qian et al, 2018, Mol Med Report CrossRef
  59. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway
    Lichao Zhu et al, 2018, Mol Med Report CrossRef
  60. Roles of microRNA-539 and osteopontin in rheumatoid arthritis
    Yan Liu et al, 2017, Exp Ther Med CrossRef
  61. Downregulation of microRNA‑204 increases the expression of matrix metallopeptidase 9 in pediatric patients with pulpitis and Helicobacter�pylori infection in the stomach
    Shu Zhou et al, 2019, Exp Ther Med CrossRef
  62. MicroRNA‑429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
    Zhengming Su et al, 2019, mol clin onc CrossRef
  63. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
    Kyoko Oura et al, 2020, IJMS CrossRef
  64. miR-155, miR-191, and miR-494 as diagnostic biomarkers for oral squamous cell carcinoma and the effects of Avastin on these biomarkers.
    Naghmeh Emami et al, 2020, J Korean Assoc Oral Maxillofac Surg CrossRef
  65. Transcription elongation factor A-like 7, regulated by miR-758-3p inhibits the progression of melanoma through decreasing the expression levels of c-Myc and AKT1.
    Xilin Liu et al, 2021, Cancer Cell Int CrossRef
  66. CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.
    Lu Ren et al, 2021, Onco Targets Ther CrossRef
  67. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition
    Gaurav Joshi et al, 2021, Bioorganic Chemistry CrossRef
  68. Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance
    Wei Zhao et al, 2021, Br J Cancer CrossRef
  69. Altered expression of serum miR‐106a, miR‐19b, miR‐17, and PTEN in patients with idiopathic membranous nephropathy
    Lina Wu et al, 2021, J Clin Lab Anal CrossRef
  70. LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma
    Jiancheng Wang et al, 2021, Mol Med CrossRef
  71. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
    Zhi Zeng et al, 2021, Front. Oncol. CrossRef
  72. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
    Xinyao Hu et al, 2021, Front. Oncol. CrossRef
  73. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
    Jose J.G. Marin et al, 2021, Semin Liver Dis CrossRef
  74. microRNAs: Key players in virus‐associated hepatocellular carcinoma
    Javid Sadri Nahand et al, 2019, J Cell Physiol CrossRef
  75. lncRNA NR2F2-AS1 inhibits the methylation of miR-494 to regulate oral squamous cell carcinoma cell proliferation
    Yilei Liang et al, 2021, Archives of Oral Biology CrossRef
  76. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
    Yuanjun Lu et al, 2022, J Exp Clin Cancer Res CrossRef
  77. Noncoding RNAs in liver cancer patients
    Julie Sanceau et al, 2022 CrossRef
  78. Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma
    Xiaojing Chen et al, 2022, Journal of Oncology CrossRef
  79. miRNAs Inspirations in Hepatocellular Carcinoma: Detrimental and Favorable Aspects of Key Performers
    Hesham A. El-Mahdy et al, 2022, Pathology - Research and Practice CrossRef
  80. TLNPMD: Prediction of miRNA-Disease Associations Based on miRNA-Drug-Disease Three-Layer Heterogeneous Network
    Yi Yang et al, 2022, Molecules CrossRef
  81. Relationship Between the MicroRNAs and PI3K/AKT/mTOR Axis: Focus on Non-Small Cell Lung Cancer
    Yi Lin et al, 2022, Pathology - Research and Practice CrossRef
  82. The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer
    Sercan Ergün et al, 2023, ACAMC CrossRef
  83. Downregulation of microRNA‑494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA‑α‑mediated apoptosis
    Xinyuan Gao et al, 2023, Exp Ther Med CrossRef
  84. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
    Mario Romeo et al, 2023, Cancers CrossRef
  85. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain
    Silvia Sabattini et al, 2023, Vet Comparative Oncology CrossRef
  86. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis.
    Paola Dongiovanni et al, 2018, Int J Mol Sci CrossRef
  87. Revolutionizing HCV Therapy: microRNA Approaches in New Era of Treatment
    Maryam Shafaati et al, 2024 CrossRef
  88. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma.
    Aswathy R Devan et al, 2021, Pharmaceuticals (Basel) CrossRef